Global  

Drug touted by Trump to treat COVID-19 linked to higher death risk: study

Reuters Friday, 22 May 2020 ()
The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed.
0
shares
ShareTweetSavePostSend
 
Video credit: Reuters Studio - Published
News video: Drug touted by Trump as COVID-19 treatment tied to higher death risk

Drug touted by Trump as COVID-19 treatment tied to higher death risk 01:53

The malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to increased risk of death in hospitalized COVID-19 patients, according to a large study published in the medical journal Lancet. Conway G. Gittens has the study's...

Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine [Video]

US Hospitals Cut Back On Use Of Hydroxychloroquine

President Donald Trump promoted hydroxychloroquine, a malaria drug, as a COVID-19 treatment. According to Reuters, several studies suggest the drug isn’t effective against COVID-19 and creates..

Credit: Wochit Entertainment     Duration: 00:32Published
Study focuses on risks of breast cancer after pre-invasive disease [Video]

Study focuses on risks of breast cancer after pre-invasive disease

In a breakthrough study, researchers found that the women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast..

Credit: ANI     Duration: 01:12Published

Related news from verified sources

Drug touted by Trump to treat COVID-19 linked to higher death risk - study

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
Reuters India

Hydroxychloroquine tied to increased risk of death: Study

Coronavirus patients taking the anti-malarial drug, touted and taken by Trump, had higher risk of death, new study says.
Al Jazeera

You Might Like


Tweets about this